NCT02250703View on ClinicalTrials.gov

Intranasal Dexmedetomidine Premedication in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Preoperative Sedation
Interventions
DRUG

Midazolam

oral midazolam 0.5mg/kg upto maximum dose of 15mg

DRUG

Dexmedetomidine

intranasal dexmedetomidine 2mcg/kg upto maximum dose of 100mcg

Trial Locations (1)

39216

Children's of Mississippi/University of Mississipi Medical Center, Jackson

All Listed Sponsors
lead

University of Mississippi Medical Center

OTHER

NCT02250703 - Intranasal Dexmedetomidine Premedication in Children | Biotech Hunter | Biotech Hunter